Medications

Latest obesity drug not cost-effective for adolescents

Among today's obesity drugs, Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers has found that the trendy obesity drug is not cost-effective at its current price.

Autism spectrum disorders

New research shows private equity profiting off autism services

Before 2001, neither commercial health insurance companies nor Medicaid covered services for people with autism. By 2015, thanks in large part to the advocacy of thousands of parents, all but seven states had mandates requiring ...

page 6 from 40